✦ LIBER ✦

Irinotecan plus docetaxel a first-line option for NSCLC

✍ Scribed by Sullivan, S

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel: clinical benefit in first-lin

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 200 KB

A phase II study of Gemcitabine (G) plus

✍ Ventriglia, M; Estevez, R; Cabrera, L; Spector, C; Álvarez, A.A; Cilurzo, M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 116 KB

Irinotecan plus oxaliplatin a promising

📂 Article 📅 2004 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Oxaliplatin plus irinotecan promising as

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

SCOTROC 2B: feasibility of carboplatin f

✍ Clamp, A R; Mäenpää, J; Cruickshank, D; Ledermann, J; Wilkinson, P M; Welch, R; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 119 KB

Intercalated chemotherapy and erlotinib:

✍ Zheng, Yulong; Xu, Nong; Zhou, Jianying 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 38 KB